1.54 USD
↘ 0.06 (3.75%)AT CLOSE (11:59 AM EDT)
Aldeyra Therapeutics, Inc.
ALDXNASDAQ • USD
1.51
↘ 0.03 (1.69%)
POST MARKET (AS OF 07:59 PM EDT)
Post Market
AS OF 07:59 PM EDT
1.51
↘ 0.03 (1.69%)
Market: CLOSED
ALDX is currently priced at $1.54. Technical and fundamental signals converge bearish — technicals rate "Strong Sell" while fundamentals read "Sell". Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, ALDX appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Jul 31, 2026.
Open?$1.62
High?$1.63
Low?$1.52
Prev. Close?$1.60
Volume?576.8K
Avg. Volume?1.8M
VWAP?$1.56
Rel. Volume?0.33x
Bid / Ask
Bid?$1.34 × 100
Ask?$1.86 × 100
Spread?$0.52
Midpoint?$1.60
Valuation & Ratios
Market Cap?92.9M
Shares Out?60.3M
Float?49.5M
Float %?82.2%
P/E Ratio?N/A
P/B Ratio?2.20
EPS?-$0.45
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma, and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
Address
131 HARTWELL AVENUE
LEXINGTON, MA 02421
Phone: 781-761-4904
LEXINGTON, MA 02421
Phone: 781-761-4904
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?77
Short Sent.?76
Piotroski F-Score?0/9Weak
Altman Z-Score?-8.62Distress
Confidence?41%Low
Short InterestElevated
Short % of Float?7.27%Elevated
Short Interest?3.6M
Days to Cover?2.0
Free Float49.5M
Avg Daily Volume1.8M
Settlement Date2026-07-15
Financial Health
Current Ratio?2.72Strong
Quick Ratio?2.72Strong
Cash Ratio?2.67Strong
Debt/Equity?0.36Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.20CHEAP▾
Peers100
S&P70
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-1.5CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-64.9%WEAK▾
S&P3
ROA?-41.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$43.2M
Fundamentals ratios updated end of day